SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Banner Corporation's Board authorized a repurchase of up to 1.7 million shares (approximately 5% of outstanding stock), which constitutes a return of capital to shareholders. Share repurchase programs are classified as dividend_distribution events under the taxonomy, as they represent a distribution or return of capital to holders alongside regular dividends and special distributions.
View raw filing on EDGAR →The disclosure announces the Reserve Bank of India's approval of the re-appointment of Mr. Ajay Kumar Gupta as Executive Director for a further two-year term (November 27, 2026 to November 26, 2028), following earlier Board approval and pending shareholder approval at the August 21, 2026 Annual General Meeting. This is a material executive appointment requiring regulatory and shareholder approval.
View raw filing on EDGAR →Sleep Number completed the sale of substantially all of its assets to SNBR, Inc. (a subsidiary of Sleep Country Canada Inc.) on July 31, 2026, pursuant to a Bankruptcy Court-approved Asset Purchase Agreement. The transaction generated $529.5 million in cash proceeds and represents a material disposition of assets in the context of the company's Chapter 11 bankruptcy filing, with the company's common stock to be cancelled upon plan effectiveness.
View raw filing on EDGAR →Jim Rozakis was appointed President and COO effective August 1, 2026, representing a significant promotion from his prior role as Executive Vice President and COO. While the disclosure also includes compensatory arrangements (base salary of $900,000, target cash incentive of $1,125,000, target long-term incentive of $4,000,000, and one-time equity awards), the principal disclosed action is the appointment to the President role in connection with the separation of President and CEO titles. This is material as it reflects a material change in executive leadership structure.
View raw filing on EDGAR →Integer Holdings Corp has entered into a definitive agreement to be acquired by KKR affiliates for $127 per share in an all-cash transaction valued at approximately $5.7 billion enterprise value. The transaction requires stockholder approval and regulatory clearance, with expected closing by year-end 2026.
View raw filing on EDGAR →The 6-K discloses that Grupo Aval made a dividend payment in August 2026 pursuant to the profit distribution approved by shareholders on March 27, 2026. This is a routine but material capital distribution to shareholders, falling squarely within the dividend_distribution category.
View raw filing on EDGAR →Teck announced commencement of consent solicitations relating to six series of outstanding notes totaling approximately $1.03 billion in aggregate principal amount. The solicitations seek to amend covenants and events of default in the existing debt indentures, with potential for Anglo Teck to provide a full guarantee post-merger. While this is technically a modification of existing debt obligations rather than issuance of new debt, the material restructuring of debt terms and potential guarantee constitute a significant financial obligation event material to investors assessing the company's capital structure and credit profile.
View raw filing on EDGAR →The filing discloses entry into supplemental indentures that materially modify the Company's existing debt obligations by converting cash interest payments into principal increases and issuing additional notes as payment-in-kind and consent fees. While this is technically an amendment to existing debt rather than a new issuance, the creation of additional principal amount ($400.9M and $58.9M respectively) and the issuance of new notes as consideration constitute a material modification of direct financial obligations. The covenant_breach classification does not apply because there is no evidence of a default or triggering event; rather, this appears to be a consensual restructuring to preserve liquidity by deferring cash interest payments.
View raw filing on EDGAR →OGE Energy's Board elected Richard E. Muncrief as a new director effective August 1, 2026. The disclosure centers on the appointment of a highly qualified executive (retired President and CEO of Devon Energy) to the Board, with assignment to the Nominating, Corporate Governance and Stewardship Committee and the Audit Committee. This is a material governance event affecting board composition and oversight.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from 8x8's annual meeting held August 3, 2026, covering four proposals: election of eight directors, advisory vote on executive compensation, ratification of Grant Thornton LLP as independent auditor, and approval of an equity plan amendment. The filing presents final vote tallies for each proposal, confirming all four passed. This is a textbook Item 5.07 shareholder vote results disclosure.
View raw filing on EDGAR →The filing discloses Alexandria Real Estate Equities' second quarter 2026 financial and operating results through a press release dated August 3, 2026, with supplemental information including consolidated statements of operations, balance sheets, and detailed operating metrics. This is a standard quarterly earnings disclosure under Item 2.02, with the press release and supporting exhibits providing comprehensive financial results and guidance.
View raw filing on EDGAR →Mettler-Toledo appointed Natalia Shuman as a director effective August 3, 2026, with the Board determining she qualifies as independent under NYSE listing standards. The Board also resolved to increase its size from nine to ten directors in connection with this appointment. Shuman brings extensive executive experience including CEO roles at MISTRAS Group and Bureau Veritas North America.
View raw filing on EDGAR →ONEOK announced second-quarter 2026 financial results on August 3, 2026, disclosing net income of $967 million (up 13% year-over-year) and adjusted EBITDA of $2.12 billion (up 7%), along with increased 2026 full-year financial guidance.
View raw filing on EDGAR →This material fact discloses the results of an Extraordinary Shareholders' Meeting held on August 3, 2026, at which shareholders approved a new share repurchase program authorizing acquisition of up to 5% of LATAM's outstanding shares (28.7 billion shares) over a 5-year period. The disclosure reports the shareholder vote outcome and the specific authorizations granted to the Board of Directors regarding pricing, timing, and execution of the buyback program, which is material to investors' assessment of capital allocation and share dilution dynamics.
View raw filing on EDGAR →This is a quarterly earnings release for Q2 2026 filed under Item 2.02 (Results of Operations and Financial Condition). The press release discloses comprehensive financial results including diluted EPS of $2.90 (reported) and $3.19 (adjusted), net income of $766 million, Adjusted EBITDA of $1,592 million, and RevPAR growth of 3.4% worldwide. The filing explicitly states "On August 3, 2026, Marriott International, Inc. is issuing a press release reporting financial results for the quarter ended June 30, 2026" with the press release attached as Exhibit 99.
View raw filing on EDGAR →Shareholders approved a stock option grant to Executive Chairman Ali Mazanderani of 1,000,000 options at $5.00 per share, vesting on April 1, 2028 with exercise eligibility after April 1, 2029.
View raw filing on EDGAR →The exhibit announces the appointment of Michael Halstead as Chief Executive Officer of Helus Pharma (Cybin Inc.), effective immediately. Halstead is a highly experienced pharmaceutical executive with 25 years of industry experience, most recently President of Intra-Cellular Therapies, where he led the company through commercialization and its $14.6 billion sale to Johnson & Johnson. This is a material executive appointment at a critical juncture as the company prepares for Phase 3 topline data readout in Q4 2026.
View raw filing on EDGAR →USBC drew an additional $3.0 million fixed-rate borrowing under its Master Loan Agreement with Payward Interactive, Inc., increasing aggregate outstanding principal to $18.0 million at 8.5% interest maturing July 28, 2027, with collateral maintenance provisions tied to Bitcoin volatility.
View raw filing on EDGAR →USBC disclosed progress on its tokenized deposit product development strategy, including completion of Phase 1 technical readiness testing, initiation of Phase 2 with expanded testing, and development of USBC Pay payment functionality toward commercial launch.
View raw filing on EDGAR →The Item 2.02 disclosure announces Diversified Healthcare Trust's financial results for the quarter ended June 30, 2026, with a summary press release (Exhibit 99.1) and detailed earnings presentation (Exhibit 99.2) attached. The filing includes key financial metrics such as net loss of $(37.4)M, Normalized FFO of $38.9M, Adjusted EBITDAre of $82.1M, and updated full-year 2026 guidance. This is a standard quarterly earnings release material to investors assessing the REIT's operational and financial performance.
View raw filing on EDGAR →The Oncology Institute, Inc. changed its corporate name to Starling Oncology, Inc. and its ticker symbol from TOI to STLN, effective August 4, 2026, through a Certificate of Amendment filed with Delaware on July 28, 2026. The rebrand is material to investors as it affects the company's public identity and market recognition, though it does not alter the company's operations, assets, or economic substance.
View raw filing on EDGAR →TotalEnergies announced the divestment of its 8.5% minority non-operated interest in the Marjoram gas field in Malaysia to INPEX for USD 350 million, crystallizing value from a non-operated portfolio position and aligning with the company's strategy of managing its portfolio and focusing on operated assets.
View raw filing on EDGAR →TotalEnergies announced the first LNG cargo shipment from ECA LNG Phase 1, a project in which the company holds a 16.6% stake and will offtake 1.7 Mtpa of LNG for 20 years, representing a significant operational milestone in the company's strategy to increase natural gas in its sales mix to approximately 50% by 2030.
View raw filing on EDGAR →TotalEnergies completed the divestment of approximately 170 MW of distributed solar assets across 7 European countries to Amarenco and AMPYR Distributed Energy, aligning with the company's strategic refocus on large utility-scale renewables.
View raw filing on EDGAR →TotalEnergies announced second quarter and first half 2026 financial results, including adjusted net income of $6.0 billion and cash flow of $9.8 billion for Q2, with detailed segment performance, production figures, and forward guidance.
View raw filing on EDGAR →TotalEnergies' Board approved a second interim dividend of EUR 0.90 per share for fiscal year 2026, representing a 5.9% increase compared to 2025 distributions, with ex-dividend date of December 31, 2026 and payment dates of January 5, 2027 (Euronext) and January 22, 2027 (NYSE).
View raw filing on EDGAR →TotalEnergies' Board adopted the 2027 dividend timetable, establishing ex-dividend and payment dates for four dividends (three interim and one final) for fiscal year 2027.
View raw filing on EDGAR →TotalEnergies announced its decision to appeal a June 25, 2026 judgment rendered by the Paris Judicial Court in a duty of vigilance climate case brought by certain associations under French law, representing a material legal development affecting the company's regulatory and legal exposure.
View raw filing on EDGAR →TotalEnergies and Eni took a Final Investment Decision (FID) for the development of the Cronos gas field in Cyprus, representing a material capital commitment to a new offshore gas development project with production start-up in 2028 and integration with existing Egyptian LNG facilities.
View raw filing on EDGAR →The filing discloses Skyworks Solutions' entry into a definitive Merger Agreement with Qorvo, Inc. on October 27, 2025, involving a two-step merger structure where Qorvo shareholders will receive 0.960 Skyworks shares plus $32.50 cash per share, resulting in approximately 37% Qorvo and 63% Skyworks ownership post-closing. This is a material acquisition/change of control transaction with significant regulatory milestones (FTC Second Request, stockholder approvals on February 11, 2026) and debt exchange offers underway, clearly meeting the definition of ma_activity under Items 1.01/2.01.
View raw filing on EDGAR →This Item 8.01 disclosure updates the status of a material acquisition: Skyworks' merger with Qorvo, originally announced October 27, 2025. The filing reports that HSR antitrust clearance has been obtained (waiting period expired, FTC allowed Timing Agreement to expire August 1, 2026), foreign investment approvals have been cleared in most jurisdictions, and only China and South Korea remain open. The company expects closing within calendar year 2026. This is a completion-stage update on a transformative M&A transaction that would combine two major semiconductor companies.
View raw filing on EDGAR →This exhibit is a monthly delivery update announcing July 2026 vehicle deliveries (35,934 units, +71% YoY) and cumulative milestones (1.22M vehicles delivered, ES8 reaching 130K units). While not a formal earnings release with comprehensive financial results, the strong YoY growth and product-line performance metrics are operationally significant and would inform investor assessment of NIO's market execution and demand trajectory. The disclosure is material to operational performance but does not constitute a periodic financial report or earnings release with full financial statements.
View raw filing on EDGAR →Supernus Pharmaceuticals entered into a definitive Merger Agreement with Indivior Pharmaceuticals on August 1, 2026, establishing a tax-free all-stock merger of equals. The transaction includes an exchange ratio of 1.5401 Indivior shares per Supernus share, a $1 billion special dividend to Indivior shareholders, $650 million in committed financing, and is expected to close in Q4 2026, creating a combined CNS biopharmaceutical company with approximately $2.2 billion in pro forma annual revenues.
View raw filing on EDGAR →Jack A. Khattar, CEO of Supernus Pharmaceuticals, executed a Second Amended and Restated Employment Agreement in connection with the merger, specifying a base salary of $1,115,000, annual cash bonus targeted at 100% of base salary (up to 200%), severance provisions of 18–24 months depending on timing, and full vesting of stock-based awards upon termination without cause or for good reason.
View raw filing on EDGAR →The Eleventh Amendment reflects a series of covenant modifications and payment deferrals on the Company's credit facility, signaling financial distress. The reduction of the minimum liquidity covenant from $7.5 million to $6.25 million, combined with the deferral of a $9+ million principal payment originally due June 30, 2026 (now due August 31, 2026), and the requirement to enter into a capital transaction or debt repayment agreement by August 10, 2026, all indicate the Company is in technical default or near-default on its existing obligations. While the filing is styled as an amendment agreement rather than a breach notice, the substance—repeated deferrals, covenant relaxations, and lender-imposed transaction deadlines—reflects a triggering event that materially increases financial obligations and signals covenant stress.
View raw filing on EDGAR →This is a press release announcing Luckin Coffee's unaudited financial results for the second quarter ended June 30, 2026. The document discloses quarterly net revenues (RMB15.9 billion, up 28.5% YoY), GAAP operating income (RMB2.1 billion, up 22.0% YoY), net income (RMB1.5 billion, up 16.1% YoY), and key operating metrics including store count and customer growth. This is a discrete earnings announcement, not a periodic financial report filing, and the results are material to investors assessing the registrant's financial performance and growth trajectory.
View raw filing on EDGAR →Two Harbors announced receipt of all but one required state regulatory approval for its previously announced merger with CrossCountry Intermediate Holdco, LLC, with closing expected the business day after final approval is received. This is a material acquisition/change of control event (Item 1.01/2.01 territory) disclosed under Item 7.01 Regulation FD. The disclosure addresses the status and expected timing of a major transaction that would materially affect the registrant.
View raw filing on EDGAR →SmartKem entered into a definitive Business Combination Agreement to acquire Ferrox Critical Minerals in an all-stock transaction valued at approximately $125 million, extending SmartKem's materials platform into critical minerals.
View raw filing on EDGAR →This is a clear earnings release disclosing Ocular Therapeutix's financial results for Q2 2026 (quarter ended June 30, 2026), filed on August 3, 2026 under Item 2.02. The press release reports total net revenue of $13.5 million, R&D expenses of $54.1 million, and a net loss of $(78.8) million, along with cash position of $598.6 million and runway into 2028. The disclosure is material as it provides investors with the company's quarterly financial performance and liquidity position.
View raw filing on EDGAR →This is a press release announcing Sportradar's second quarter 2026 financial results, including revenue of €378 million (up 19% YoY), Adjusted EBITDA of €76 million (up 19%), and updated full-year 2026 guidance. The disclosure presents quarterly financial performance metrics, operating highlights, and forward-looking revenue and EBITDA guidance, which are hallmarks of an earnings release. Material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →This is a completion of a material acquisition disclosed under Item 2.01. Brookfield acquired the remaining 26% interest in Oaktree for approximately $3.0 billion in cash and shares, achieving 100% ownership of a major credit platform. The transaction is material to investors as it significantly expands Brookfield's $365B credit platform and represents a major strategic consolidation of a previously announced partnership.
View raw filing on EDGAR →The filing discloses the appointment of Indira Agarwal as Senior Vice President, Chief Financial Officer, effective August 1, 2026, succeeding Damon Audia who was promoted to President of PTx & Corporate Strategy. While the filing also documents Agarwal's compensatory arrangement (base salary of $600,000, incentive compensation, and severance terms), the principal disclosed action centers on her appointment to the CFO role and Audia's promotion to a new strategic position. The appointment of a new CFO is material to investors as it affects the company's financial leadership and governance structure.
View raw filing on EDGAR →Deidra C. Merriwether, the Senior Vice President and Chief Financial Officer, resigned effective September 4, 2026. While the disclosure also includes the appointment of Laurie R. Thomson as interim CFO and her compensatory arrangements, the principal disclosed action centers on the departure of the CFO—a named executive officer whose resignation is material to investors assessing leadership continuity and financial oversight.
View raw filing on EDGAR →Cohen & Company Inc. issued a press release on August 3, 2026, announcing financial results for the second quarter ended June 30, 2026. The disclosure includes revenue of $69.5 million, net income of $3.6 million ($0.94 per diluted share), and adjusted pre-tax income of $10.1 million ($1.62 per diluted share), along with a board declaration of a quarterly dividend of $0.25 per share. This is a standard quarterly earnings release filed under Item 2.02 with the earnings release attached as Exhibit 99.1.
View raw filing on EDGAR →Charter Communications is disclosing unaudited interim financial statements and pro forma financial information for Cox Communications in connection with a material acquisition transaction. The Transaction Agreement, entered into May 16, 2025, involves Charter acquiring Cox's commercial fiber and managed IT/cloud services businesses and Cox Communications' residential cable business (with Cox Enterprises contributing equity interests and paying $1.00 to Charter). The filing explicitly states this is to "provide the unaudited interim condensed consolidated financial statements of Cox Communications" and "pro forma financial information regarding the Transactions," reflecting the impact as if the transaction had occurred. This is a material M&A disclosure under Item 8.01 (Other Events) providing financial context for a previously announced major acquisition.
View raw filing on EDGAR →The Item 8.01 disclosure announces a proposed merger of equals between Supernus Pharmaceuticals and Indivior Pharmaceuticals, structured as a 100% tax-free stock-for-stock transaction with a fixed exchange ratio of 1.5401 Indivior shares per Supernus share. The filing explicitly states the companies are "hosting a conference call and webcast at 8:30 a.m., Eastern Time, to present information regarding the proposed merger" and references a joint proxy statement/prospectus to be filed. This is a material acquisition/merger activity that would substantially affect the registrant's business, ownership structure, and financial profile, creating a combined $2.2 billion CNS biopharmaceutical company.
View raw filing on EDGAR →Esquire Financial Holdings completed its merger with Signature Bancorporation effective August 1, 2026, pursuant to a Merger Agreement dated March 11, 2026. The combined entity has approximately $4.8 billion in total assets, $3.3 billion in loans, and $4.0 billion in deposits, materially expanding Esquire's asset base and geographic footprint into the Chicago and Midwest markets.
View raw filing on EDGAR →Michael G. O'Rourke and Leonard S. Caronia were appointed to Esquire Financial Holdings' board of directors effective upon completion of the Signature merger on August 1, 2026. O'Rourke also assumed the role of President of the Signature division.
View raw filing on EDGAR →The section discloses the appointment of David Kutil as Chief Financial Officer on July 28, 2026, along with material terms of his employment agreement including base salary of $275,000 and bonus eligibility. While the section also mentions termination of Sefton Cohen as Chief Revenue Officer, the primary focus and detail is on Kutil's appointment to a named executive officer role, making exec_appointment the most salient event. The appointment of a CFO is material to investors as it affects the registrant's financial leadership and governance.
View raw filing on EDGAR →The filing discloses a board-approved cash dividend declaration of $0.73 per share payable to shareholders of record as of August 14, 2026, with payment on August 28, 2026. This is a straightforward dividend distribution event. The company emphasizes this reflects "sustained financial strength" and a "60 years of positive earnings" track record, making it material to investor assessment of capital allocation and financial health.
View raw filing on EDGAR →